drugset / Trial / NCT03699995

MoleMapper, Visiomed, and Confocal Microscopy in Screening Participants for Melanoma

NCT03699995 ↗

NaSingle-groupOpen-labelScreening

Summary

This trial studies how well MoleMapper, Visiomed, and confocal microscopy work in screening participants for melanoma. Analyzing images (photographs) made with three different portable imaging systems may be as good as a visit to a dermatologist's office for finding melanomas before they can spread.

Timeline

Start
2018-05-18
Primary completion
2025-12-31
Completion
2025-12-31

Outcome

Outcome not reported

Stopped (Enrollment): “The study did not meet its accrual goals due to the departure of study personnel. Study team opted for a study closure due to loss of key personnel.”

Drugs

EvaluationDrugModalityDoseRoute
Background Lidocaine Other / unclassified — Subcutaneous